Latest News

The agreement establishes a framework for joint action against Bundibugyo virus disease, viral haemorrhagic fevers, cholera and other infectious disease threats that could spread across the border.

The shift also comes as pharmaceutical companies invest in newer technologies that could change how influenza vaccines are developed and manufactured.

The Photon Counting Sensor Fab is the only facility of its kind in Europe and will produce semiconductor sensors used in advanced X-ray imaging.

Exegenesis Bio designed EMC181 to improve the delivery of genetic medicines to muscle tissue while limiting exposure to the liver.

The distribution centre processes approximately 75,000 transactions each day, supporting Aster’s network of 350 pharmacies, 120 medical clinics and 15 hospitals across the UAE.

Following the transaction, the LSDx business will operate independently under the name Aluris Sciences.

The investment, which is approaching KSh 1 billion (US$7.7 million), is expected to reduce the distance patients travel to access specialist ophthalmic services.

Axogen expects to complete the transaction in the fourth quarter of 2026, adding BioCircuit’s NerveTape to its portfolio.

The decision follows WHO’s prequalification of the vaccine’s single dose presentation in March 2025 and Gavi’s decision in July 2025 to establish a maternal RSV vaccine programme.

NAFDAC selected the 600 pharmacists from all 36 states and the Federal Capital Territory (FCT).